Genomics of Posttraumatic Stress Disorder in Veterans
Key facts
- Who runs it
- VA Office of Research and Development
- Where
- San Diego, United StatesSee the site
- Trial code
- Status
- Completed
- People taking part
- 20,000 people enrolled
- Started
- 1 Dec 2013
- Ended
- 30 Sept 2024
- Type of study
- Observational
- Record updated
- 3 October 2024
Who can take part
- Age
- 18 years to 80 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 3 criteriaShow less
Who can take part
- Combat-exposed Veterans who participated in the Million Veteran Program
Who cannot take part
- bipolar disorder
- schizophrenia
Where in United States
- VA San Diego Healthcare System, San Diego, CASan Diego, United States
About the trial
What the trial wants to find out
Posttraumatic Stress Disorder (PTSD), as a common and serious mental health condition, affects about 25% of all military personnel that have served in combat. People suffering from PTSD may experience traumatic flashbacks, trouble sleeping, and problems in their relationships. This study is intended to help identify genes that influence and increase the risk of PTSD, to improve ways of detecting and treating the condition in the future.
Read full original descriptionShow less
Previous research has studied genes that increase the risk of PTSD, but none of these have included a Veteran-only population. The current study focuses on US Veterans, utilizing the VA Million Veteran Program (MVP) database of approximately 300,000 participants as of August 2014. In this context, participants with PTSD are referred to as "cases" and Veterans without PTSD are referred to as "controls."
This project will be done in three stages. The first stage will look at MVP-obtained data and electronic health record (EHR) data to implement methods for identifying combat-exposed case patients with PTSD and combat-exposed control patients without PTSD. The second stage will assemble and validate a study population of 20,000 participants "including 10,000 combat-exposed Veterans with PTSD as cases and 10,000 combat-exposed Veterans without PTSD as controls. The third stage will conduct genetic analyses ("genotyping") comparing the cases to controls, to identify genes associated with increased risk of developing the condition.
The group in the trial
- Million Veteran Program (MVP) participants
Veterans who are currently enrolled in the Million Veteran Program.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- CSP #575B - Genomics of Posttraumatic Stress Disorder Among Veterans
- Publications
- Genomics of posttraumatic stress disorder in veterans: Methods and rationale for Veterans Affairs Cooperative Study #575B.International journal of methods in psychiatric research, 2019
- Record updated
- 3 October 2024